Chief Commercial Officer of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), Yarema Kristin, buys 2,021 shares worth $29,304
According to Atara Biotherapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 15 04:02 PM, company Chief Commercial Officer, Yarema Kristin disclosed buying 2,021 shares at a cost of $14.50. At the time of this transaction (Jun 11), this trade was worth $29,304 in total. As of Jun 11, Yarema Kristin now owns 93,549 shares in total worth about $1,309,686.0.
For the last few recent trades made by Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Chief Commercial Officer, Yarema Kristin, we have the following information:
- SEC Form 4 filing: Jun 14: Bought 32,333 shares at the rate of $14.57 per share. Total worth of this trade was $471,065. Total number of shares owned as of Jun 14 were 125,882
Posted by
George Daniels
on Wednesday June 16 2021, 9:47 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
